0
Get Alert
Please Wait... Processing your request... Please Wait.
You must sign in to sign-up for alerts.

Please confirm that your email address is correct, so you can successfully receive this alert.

Letters   |    
Adjunctive Yokukansan Treatment Improved Cognitive Functions in a Patient With Schizophrenia
Shinji Sakamoto, M.D.; Hiroshi Ujike, M.D., Ph.D.; Manabu Takaki, M.D., Ph.D.; Yutaka Mizuki, M.D.; Yuko Okahisa, M.D., Ph.D.; Masafumi Kodama, M.D., Ph.D.; Yosuke Uchitomi, M.D., Ph.D.
The Journal of Neuropsychiatry and Clinical Neurosciences 2013;25:E39-E40. doi:10.1176/appi.neuropsych.12070166
View Author and Article Information

This study was supported in part by a grant from the Zikei Institute of Psychiatry.

Statement of Interest: None

Dept. of Neuropsychiatry, Okayama University Graduate School of Medicine, Dentistry, and Pharmaceutical Sciences Okayama City, Japan

Correspondence: Dr. Sakamoto; e-mail: shinjisakamoto1202@gmail.com

Copyright © 2013 American Psychiatric Association

Extract

To the Editor: Yokukansan, a traditional Asian herbal medicine, is reported to be safe and effective for behavioral and psychological symptoms of dementia in randomized, controlled trials, and is widely prescribed for patients with dementia in Japan.1 A recent open-label study indicates that adjunctive yokukansan administration in treatment-resistant schizophrenia improved the positive and negative symptoms of schizophrenia.2 In this report, we present a case of schizophrenia in which adjunctive yokukansan treatment dramatically improved severe cognitive dysfunction.

Figures in this Article

First Page Preview

View Large
/>
First page PDF preview
Your Session has timed out. Please sign back in to continue.
Sign In Your Session has timed out. Please sign back in to continue.
Sign In to Access Full Content
 
Username
Password
Sign in via Athens (What is this?)
Athens is a service for single sign-on which enables access to all of an institution's subscriptions on- or off-site.
Not a subscriber?

Subscribe Now/Learn More

PsychiatryOnline subscription options offer access to the DSM-5 library, books, journals, CME, and patient resources. This all-in-one virtual library provides psychiatrists and mental health professionals with key resources for diagnosis, treatment, research, and professional development.

Need more help? PsychiatryOnline Customer Service may be reached by emailing PsychiatryOnline@psych.org or by calling 800-368-5777 (in the U.S.) or 703-907-7322 (outside the U.S.).

FIGURE 1. Changes in BACS–J Scores With Yokukansan Treatment

Black bar shows the Z score before yokukansan treatment; gray bar shows the Z score after yokukansan treatment. [A]: verbal memory; [B]: working memory; [C]: motor speed; [D]: verbal fluency; [E]: attention and processing speed; [F]: executive function.

+

References

Mizukami  K;  Asada  T;  Kinoshita  T  et al:  A randomized cross-over study of a traditional Japanese medicine (kampo), yokukansan, in the treatment of the behavioural and psychological symptoms of dementia.  Int J Neuropsychopharmacol 2009; 12:191–199
[CrossRef] | [PubMed]
 
Miyaoka  T;  Furuya  M;  Yasuda  H  et al:  Yi-gan san as adjunctive therapy for treatment-resistant schizophrenia: an open-label study.  Clin Neuropharmacol 2009; 32:6–9
[CrossRef] | [PubMed]
 
Terawaki  K;  Ikarashi  Y;  Sekiguchi  K  et al:  Partial agonistic effect of yokukansan on human recombinant serotonin 1A receptors expressed in the membranes of Chinese hamster ovary cells.  J Ethnopharmacol 2010; 127:306–312
[CrossRef] | [PubMed]
 
Egashira  N;  Iwasaki  K;  Ishibashi  A  et al:  Repeated administration of Yokukansan inhibits DOI-induced head-twitch response and decreases expression of 5-hydroxytryptamine (5-HT)2A receptors in the prefrontal cortex.  Prog Neuropsychopharmacol Biol Psychiatry 2008; 32:1516–1520
[CrossRef] | [PubMed]
 
Kawakami  Z;  Kanno  H;  Ueki  T  et al:  Neuroprotective effects of yokukansan, a traditional Japanese medicine, on glutamate-mediated excitotoxicity in cultured cells.  Neuroscience 2009; 159:1397–1407
[CrossRef] | [PubMed]
 
References Container
+
+

CME Activity

There is currently no quiz available for this resource. Please click here to go to the CME page to find another.
Submit a Comments
Please read the other comments before you post yours. Contributors must reveal any conflict of interest.
Comments are moderated and will appear on the site at the discertion of APA editorial staff.

* = Required Field
(if multiple authors, separate names by comma)
Example: John Doe



Related Content
Books
Textbook of Psychotherapeutic Treatments > Chapter 6.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 24.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 24.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 24.  >
Dulcan's Textbook of Child and Adolescent Psychiatry > Chapter 7.  >
Topic Collections
Psychiatric News
Read more at Psychiatric News >>
APA Guidelines
PubMed Articles